Metraipolis › archive › dc_50bfbfa33376

Identification of ANT2 as a Druggable Target for Endocrine-Resistant ERα-Positive Breast Cancer — Europe PMC PMID:42074342

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42074342
DOI: 10.3390/ijms27083704
License (as archived): solo-consultazione
Archived: 2026-10-08T03:53:57.976Z
SHA-256 of the archived text: ecb1b2b80688138789b24d212f23d45d14da5e458037aa92fadeca6d75b08ffb
Stable URL of this page: https://metraipolis.com/documento/dc_50bfbfa33376

How to cite

Identification of ANT2 as a Druggable Target for Endocrine-Resistant ERα-Positive Breast Cancer — Europe PMC PMID:42074342 — Europe PMC (en), https://europepmc.org/article/MED/42074342 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_50bfbfa33376 (Metraipolis archive dc_50bfbfa33376, sha256 ecb1b2b80688138789b24d212f23d45d14da5e458037aa92fadeca6d75b08ffb)

BibTeX

@misc{dc50bfbfa33376,
  title = {Identification of ANT2 as a Druggable Target for Endocrine-Resistant ERα-Positive Breast Cancer — Europe PMC PMID:42074342},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42074342},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_50bfbfa33376; sha256 ecb1b2b80688138789b24d212f23d45d14da5e458037aa92fadeca6d75b08ffb},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42074342. Agents can read the archived copy with the MCP tool read_document.